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Abstract
Background: Direct-to-consumer (DTC) personal genotyping services are beginning to be adopted by educational
institutions as pedagogical tools for learning about human genetics. However, there is little known about student
reactions to such testing. This study investigated student experiences and attitudes towards DTC personal genome
testing.
Methods: Individual interviews were conducted with students who chose to undergo personal genotyping in the
context of an elective genetics course. Ten medical and graduate students were interviewed before genotyping
occurred, and at 2 weeks and 6 months after receiving their genotype results. Qualitative analysis of interview
transcripts assessed the expectations and experiences of students who underwent personal genotyping, how they
interpreted and applied their results; how the testing affected the quality of their learning during the course, and
what were their perceived needs for support.
Results: Students stated that personal genotyping enhanced their engagement with the course content. Although
students expressed skepticism over the clinical utility of some test results, they expressed significant enthusiasm
immediately after receiving their personal genetic analysis, and were particularly interested in results such as drug
response and carrier testing. However, few reported making behavioral changes or following up on specific results
through a healthcare provider. Students did not report utilizing genetic counseling, despite feeling strongly that
the ‘general public’ would need these services. In follow-up interviews, students exhibited poor recall on details of
the consent and biobanking agreements, but expressed little regret over their decision to undergo genotyping.
Students reported mining their raw genetic data, and conveyed a need for further consultation support in their
exploration of genetic variants.
Conclusions: Personal genotyping may improve students’ self-reported motivation and engagement with course material.
However, consultative support that is different from traditional genetic counseling will be necessary to support students.
Before incorporating personal genotyping into coursework, institutions should lead multi-disciplinary discussion to
anticipate issues and incorporate teaching mechanisms that engage the ethical, legal, and social implications of personal
genotyping, including addressing those found in this study, to go beyond what is offered by commercial providers.
Background
Direct-to-consumer (DTC) personal genomics compa-
nies provide public access to individualized genetic test-
ing outside the context of traditional healthcare systems.
For a fee, consumers may submit a saliva specimen for
analysis to obtain genetic risk information on a broad
spectrum of health conditions and behavioral traits.
Such services have prompted concerns that consumers
will approach their physicians for assistance with inter-
pretation and/or incorporation of individual results into
their healthcare management [1,2]. Furthermore, owing
to the declining costs of personal genomic testing, some
hospitals in the USA and other countries have begun to
introduce genomic analysis to make pharmacogenetic
testing available to patients [3-5]. However, physicians
are often ill equipped to interpret or utilize these genetic
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profiles, prompting calls to educate healthcare providers
on genome-wide association studies and on medical
genetics more generally [6-10]. Consequently, several
institutions have begun to consider, and in some cases
offer, courses that incorporate genomic testing of stu-
dents as an innovative pedagogical approach to teaching
human genetics [11-14].
Although there is widespread agreement about the
need for improved medical education in genomic medi-
cine, there are few models for creating effective mechan-
isms and content within existing curricula to achieve
these goals [15-18]. Recently, personal genotyping has
gained attention as a way to increase medical profes-
sionals’ knowledge of emerging genetic technologies and
scientific discovery, and to engender excitement and
motivation among students as a way of encouraging
them to learn and engage with genetics [7-11,19,20].
In 2009, a medical school elective course was proposed
at Stanford University to expose physician-scientist trai-
nees to the design, use, and interpretation of genetic stu-
dies of human populations and diseases [14]. The course,
GENE 210 ‘Genomics and Personalized Medicine’ aimed
to educate students on the analysis and interpretation of
individual genome data as it relates to disease risk, phar-
macogenomics, and human ancestry [21]. In an effort to
augment the learning environment, course instructors
proposed that students should have the option to use their
own genotype data in classroom exercises. To review this
new approach, a multi-disciplinary task force consisting of
faculty members in genetics, genetic counseling, law,
ethics, education, and clinical departments, convened to
discuss the proposal and to explore the risks of incorporat-
ing DTC personal genetic testing into the elective medical
school course [14,19]. Through this process, the university
task force identified 8 potential ethical challenges and
their possible solutions. As described in Figure 1, these
issues were confidentiality, conflict of interest, risk of coer-
cion, informational risks, informed decision-making, finan-
cial accessibility, genetic counseling, and unknown issues
due to the experimental nature of the new course [19].
The task force made several recommendations to address
these concerns, such as offering the option for carefully
subsidized testing through two different companies
(23andMe, Inc. or Navigenics), establishing a strict policy
of anonymity, offering free genetic counseling, and obtain-
ing approval for use of human subjects for the empirical
study of the course method [19]. These recommendations
were implemented when the course was first offered dur-
ing the summer quarter of 2010.
The course at Stanford is now one of several across
the USA that has incorporated personal genotyping as a
pedagogical tool in teaching human genetics, reflecting
growing interest in institutions for such approaches
[7-11,19,20]. However, as yet, there have been no
empirical studies of student experience with this
method. In this study, we explored the perspectives of
students who had undergone personal genotyping in a
course context, by conducting a series of individual
interviews with students enrolled in GENE 210 before
and after genotyping. Our specific research questions
were as follows. 1) What are the expectations of stu-
dents choosing to undergo personal genotyping? 2) How
do students interpret and apply their genetic results? 3)
What do students understand to be their relationship
with DTC genetic testing commercial providers? 4)
What type of support, if any, do students need?
Methods
Ethics approval
The research conformed to the Declaration of Helsinki’s
Ethical Principles for Medical Research Involving
Human Subjects, and was approved by the Stanford
Institutional Review Board. Students gave written and
oral informed consent to participate in the study.
Participants
We recruited study participants from the 46 students
enrolled in GENE 210: ‘Genomics and Personalized
Medicine’ at Stanford University School of Medicine
offered in the summer of 2010 http://gene210.stanford.
edu/. During the 8-week course, students analyzed
whole-genome single nucleotide polymorphism (SNP)
data, and were given a choice of using their own data or
publicly available genotype data from 12 HapMap
participants.
To recruit participants, we distributed an email
announcement that included details of the study to
registered enrollees at the beginning of the course, and
instructors announced information about the study in
class. Enrollment in the study was limited to students
who elected to use the personal genotyping offered
through the course, who were over the age of 18 years
old, and who agreed to participate in open ended, in-
depth individual interviews. The identities of student
participants were kept confidential. No instructors were
involved in the enrollment of study participants, and the
decision to participate was strictly voluntary and not
linked in any way to student evaluations or grades in
the course.
Interviews
Students recruited for this study participated in three in-
depth individual interviews (with author SL), each last-
ing approximately 90 to 120 minutes. The first interview
occurred before students received their genotyping
results, followed by a second interview 2 weeks after
receiving their results, and a final interview approxi-
mately 6 months later.
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Interviews included questions probing student per-
spectives on course expectations, understanding of
informed consent, confidentiality of participant identity
and genotype data, interpretation and application of test
results, experiences sharing genotype data, and attitudes
towards the pedagogical value of personal genotyping.
Data analysis
Analysis of interview data was based on the principles of
grounded theory, which offers systematic procedures
that move from description to analysis, and enables the-
ories to be developed inductively. Analysis of interview
data began with open coding, using the qualitative soft-
ware program MAXQDA (VERBI GmBH, Berlin, Ger-
many). This inductive method examines phenomena
within the interview text, and categorizes statements
through codes that are developed within a larger frame-
work. In addition, selective coding of the data, focusing
on categories and including behavioral changes,
informed consent, and personal utility, was analyzed for
themes across the three sets of interviews. Intra-coder
and inter-coder reliability was maximized in several
ways. Differences were reconciled to establish an initial
coding scheme. Periodic joint coding of data ensured
continued inter-coder reliability. Approximately 10% of
the data were cross-coded (by author SL) and re-coded
(author SV) to ensure intra-coder consistency over time.
Any coding differences encountered were discussed and
reconciled through consultation with the research team.
Results
Participant characteristics are described in Table 1; 50%
were female and self-identified as Caucasian. Because
GENE 210 was a graduate-level elective course, all parti-
cipants were advanced students, with three participants
enrolled in clinical programs (medical school or clinical
fellowship) and seven enrolled in biological sciences
programs (graduate school or post-doctoral fellowship).
All participants chose the personal genotyping offered
through 23andMe, Inc. Significant changes in attitudes
and reported reactions to genotyping experiences
Figure 1 Issues addressed by the university task force review.
Table 1 Participant characteristics
Characteristics No. (%)
Female gender 5 (50.0)
Program
Medical (MD, clinical resident/Fellow) 4 (40.0)
Graduate (PhD, post-doctoral Fellow) 6 (60.0)
Caucasian 5 (50.0)
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between the initial interviews and those conducted
6 months later were minimal. The findings reported
here reflect the major themes that emerged from the
three sets of interviews.
Student perspectives on the pedagogical value of
genotyping
Students overwhelmingly felt that using their own geno-
type data in the context of the course was personally
motivating in learning the course material. This senti-
ment was expressed throughout the three sets of inter-
views. One graduate student reflected on his experience
by emphasizing the value of testing as a pedagogical
tool.
’I think people will be more motivated to do a lot of
exercises in class with their own data and therefore,
once we got our own data, a lot of people were
excited about it and were happy to use their own
data for the other exercises. And I even went back
and redid some of the old stuff, based on my data.
So I think there was definitely a benefit... I don’t
think there’s anything specific that would make the
education less valuable by using the dummy datasets
they provided. I think there’s a more personal edge
to it when you’re using your own data, so there’s
more motivation to learn about it.’
Moreover, students training in medicine felt that their
testing experience provided them with valuable insight
into what patients who elect to undergo personal
genetic testing might experience when they see their
test results. One medical student reflected this by stat-
ing,
’I think that getting personally genotyped is really
important because it is easy to tell anyone, ‘oh, yeah,
you should get genotyped!’ But if you haven’t gone
through it - the personal feelings, emotions, and
thought process behind it - I feel like it’s hard to tell
someone else to do it. It’s hard as a medical doctor.
How can you recommend that to your patients if
you haven’t actually thought about it, because it’s
such an emotional, personal thing. So I think it’s
really important to take this course.’
Students emphasized that personal genotyping pro-
moted their engagement with the course material. Stu-
dents described the benefit of reflecting on the social,
ethical, and policy implications of genetic testing pre-
sented in lectures and class discussions during the
course. Participants reported thinking more deeply about
the risks and benefits related to testing as a result of their
experience in the class. For example, issues of privacy
and anonymity of genotype data were discussed by sev-
eral students.
‘We discussed this in class - that this is a privacy
issue and that nothing is more unique than your
genotype. It’s your fingerprint. There are people out
there right now who are saying that they can figure
out where people are from, within a hundred kilo-
meters, based on their genotype, based on just
550,000 SNPs. And I think that’s concerning about
genotyping data.’
They also described having a greater understanding of
the social issues related to testing patients than the gen-
eral population, articulating the potential value of perso-
nal experience with genotyping in bridging the gap
between healthcare providers and patients.
Student attitudes towards clinical utility and application
of genotyping results
Despite the strong views of participants that self-testing
promoted enhanced learning of course material, most
students expressed skepticism over the clinical utility of
their results related to risk prediction for complex dis-
eases (for example, heart disease, cancer, diabetes) and
were dismissive of results related to behavioral traits,
such as cognitive ability and athleticism. Conversely,
participants did state that genetic results related to drug
response and to carrier traits offered more value. For
example, every participant identified drug-response
information, such as sensitivity to warfarin, as poten-
tially useful, and noted the practical personal utility of
carrier testing. During her interview 2 weeks after
receiving her test results, one graduate student described
the potential actionability of learning she is a carrier for
a monogenic disease:
‘Knowing that I’m a carrier for this is something... it
makes things much easier to deal with, because you
can actually do something. It’s real easy to get tested
for it, and you can actually take corrective steps if
you want to. You can get your partner tested, you
can do IVF if you’re really worried about it...’
When asked if the participant would ask her partner
to be tested for the condition for which she was found
to be a carrier, she answered that her partner was plan-
ning to be tested. When asked about the partner’s deci-
sion in the follow-up interview 6 months later, the
participant said that her partner had not yet been tested,
explaining,
‘He’s probably going to get tested for it. I am not
sure when. It seemed like a big deal for us when I
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first got my results but, honestly, we haven’t thought
much about it lately. I guess you could say it fell
down on the list of things to do.’
Carrier-testing results were received with great interest,
more so than other test results returned to participants,
and in several cases, participants reported that the test
results triggered conversations between participants and
their partners about the meaning of results for reproductive
decisions. However, in the 6-month follow-up interviews,
there was little indication that carrier or pharmacogenetic
testing prompted specific actions for participants. Given
that students were not taking the relevant drugs or making
imminent family-planning decisions at the time of the
study, it is unclear whether the 6-month time frame of the
study was sufficient to determine whether testing informa-
tion would eventually prompt behavioral changes or health
management decisions.
Students did report intentions to make modest beha-
vioral changes as a result of risk predictions of complex
diseases and conditions. For example, 2 weeks after
receiving their results, students reported plans to
improve their diet, exercise more regularly, and wear
sunglasses when outside. In one case, a student said she
intended to consume dairy products more conscien-
tiously in light of test results that indicated a high likeli-
hood of lactose intolerance, in order to stave off
developing the condition. However, with the exception
of this last example, students did not report making sig-
nificant progress on these intentions in interviews 6
months after receiving their genotype results.
Student perspectives on consultative support
Although all students were given the option of consult-
ing independent genetic-counseling services before and
after testing at no additional charge, utilization of these
services was very low. Participants felt that they were
well equipped to interpret their test results on their
own; consequently, only one student participant
expressed any interest in this offering. By contrast, parti-
cipants on the whole felt strongly that genetic-counsel-
ing services would be important for the general public.
One participant explained,
‘Because I am a student in biosciences, I feel like I
can interpret the data myself, and so in that sense I
would personally resent having to go through a doc-
tor to get my genome information. But, maybe I’m
being a little paternalistic in that I think for the gen-
eral public, they should go through their doctors to
get information like this.’
Although only one participant had specific training in
clinical genetics, none of the participants felt that
genetic-counseling services should be required of stu-
dents enrolled in the course.
Most of the study participants reported that they had
used or planned to use the bioinformatics tools pre-
sented in the course to browse their genome for results
not returned by their DTC personal genomics provider.
Most commonly, students had used their raw data to
assess their relative risk for conditions known in their
family history, but all participants also mentioned
mining their data for a broad range of reported variants,
using outside sources, such as SNPedia http://www.
snpedia.com/index.php/SNPedia. For example, although
at the time, 23andMe Inc. did not offer analysis of the
apolipoprotein E (APOE) locus, which is associated with
the onset of Alzheimer’s disease, nearly all of the partici-
pants had already searched for or planned to check their
likely APOE status using their raw data.
Several participants said that they needed more indivi-
dualized help analyzing their raw dataset when mining it
for additional information. Their questions focused on
technical questions about the mining process itself, and
only secondarily about the clinical utility of a particular
finding. One participant suggested that the ethical
guidelines established to ensure confidentiality in the
course impeded the students’ ability to get the help they
needed. He explained,
‘I think there were issues with the course that could
be improved. For example, one of the issues was we
weren’t supposed to tell any instructors that we got
genotyped. So, this actually was, in some ways, really
hobbling, because if you had a specific question
about how to analyze data, because of a certain
population structure you were observing, but you
couldn’t... So, because of the way the class was struc-
tured to provide complete anonymity, it basically
meant that the class was not a resource for your per-
sonal genomics information.’
Several students who were eager to apply the bioinfor-
matics tools they had learned in the course on their
own data felt stymied by the inability to discuss their
personal results with instructors who might help them
with their analyses.
Student experiences of informed consent
When participants were asked about the details of the
consent form provided online by the genetic testing ser-
vices, none of the participants could accurately recall
the details of the agreement. Nor could any of the parti-
cipants fully describe the conditions of biobanking, an
option offered by 23andMe, Inc. to store genetic sam-
ples with the company for further study, including com-
pany-sponsored research. All but two participants
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elected for their samples to be biobanked. However,
none of these individuals could accurately describe how
long samples would be stored; what, if any, personal
information would be stored with samples; and whether
they had the option of withdrawing their samples once
enrolled. One participant answered,
‘... you know, I didn’t read all the legal stuff about
it... I guess it was... the general understanding was
that they... they use it, you know, they... Honestly,
I’m not sure... my name isn’t necessarily tied to the
studies that they’ll use. I’m sure they have some
information I’m associated with, but... um, and that
it would be used for their private research of some
kind... I don’t know what that all involves, I guess
(chuckles)’
Most students admitted to not reading all the legal
terms and conditions regarding the 23andMe Inc. bio-
banking program, and were unsure of how their perso-
nal information or genetic data might be used by the
company for research purposes. Although participants
could not describe the content of the consent and bio-
banking agreements well, none of the participants
expressed concern over their lack of recall. All partici-
pants stated that, given the opportunity, they would
have chosen self-testing as part of the course again,
expressing few regrets over their decisions.
Discussion
The advancing pace of genetic discovery has created a
widening gap in medical education. To promote genetic
literacy among students, several institutions are incor-
porating personal genotyping in the classroom [7-11,19].
We report here one of the first studies of student
experiences with genotyping used as a pedagogical tool
to teach human genetics. This study was limited to the
perspectives of those students who elected to use geno-
typing and who had advanced training in medicine and
various scientific fields (although little, if any, training in
clinical genetics). Results from the pre-testing and post-
testing interviews with study participants suggest that
students perceived positive benefits from using their
own genetic data. Participants described using their own
genetic data in the classroom as personally motivating,
and felt it provided insight into the patient experience.
Participants valued the faculty-led discussion of the ethi-
cal and legal issues related to personal genetic testing,
and stated that these allowed them to consider dimen-
sions to their decision that they had not identified prior
to the course. Our findings also indicate that the careful
consideration by the university task force of how the
course should be executed resulted in measures being
put in place that mitigated potential problems. For
example, participants specifically cited that setting the
price of the testing at $99 forced participants to care-
fully consider their decision in ways that a completely
free test might not.
The study results also indicate a need for new models
of consultative support for students who undergo self-
testing. Our study findings indicate an underutilization
of genetic-counseling services. Although few studies
have examined consumer decisions to seek genetic
counseling, this result is consistent with a survey based
study conducted by Kaufman et al., [22] in which a
mere 1% of participants sought out genetic counseling
when interpreting their results [23]. Our study result
may be explained in part by the biased perception of the
students undergoing personal genotyping that, unlike
the general population, they possessed sufficient knowl-
edge to interpret their results. However, more research
is needed to determine whether such sentiments are evi-
dent among other DTC personal genomics clientele.
Consistent with the few empirical studies that have
examined the behavioral responses of consumers of
DTC genetic testing services, our study results provide
little evidence to suggest that the mere provision of
genetic information alone results in widespread changes
in health behaviors [2,23]. Although students did report
their intention to make modest behavioral changes as a
result of risk predictions of complex diseases and condi-
tions shortly after receiving their results, none had made
any clinical changes or pursued follow-up care with
healthcare providers 6 months later.
The finding that many of our participants placed a
high value on carrier-testing information and their rele-
vance for reproductive decision-making suggests the
need to attend to the specific concerns of student popu-
lations when genotyping is offered in coursework.
Although our participants took little, if any, action
based on their carrier-testing results, the age range of
the study participants coincided with the age at which
many students may be concerned with reproductive
decisions but may not be compelled to act on these
within the 6-month period of the study, and are too
young and relatively healthy to be motivated about
other health risks. Careful consideration must be given
as to how to best support students in interpreting these
results, as previous studies indicate that carrier-testing
results significantly affect future reproductive decision-
making, and individuals may have difficulty understand-
ing risk prediction, owing to a lack of understanding of
the potential for false-negative results [24-27]. The
potential for misinterpretation and the low probability
that students will access counseling on a voluntary basis
point to the need for new models for clinical consulta-
tion and clear institutional policies regarding counseling
of student populations in the context of coursework.
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Our results also indicate that students may need new
models for technical consultation with instructors or
other experts who could answer questions about the
application of bioinformatics tools to personal genetic
data. Students felt that confidentiality guidelines prohib-
ited instructors from discussing and clarifying individual
results. Their desire for more individualized attention
reflects a tendency by students to conflate the aim of
using personal genotyping in coursework to learn general
concepts in human genetics with an opportunity to inter-
pret their own personal genotype data. Recognizing the
student inclination to mine their personal genome, this
study indicates a potential need for technical consultants
who are not responsible for coursework evaluations and
who could offer confidential expertise to students who
choose to use the knowledge they learned in the course
to analyze their own data. Given the wide availability of
web-based tools and platforms, it is reasonable to expect
that students will probe their raw data for information on
variants beyond what is given to them by a particular
testing service. Harris et al. [28] have identified the
expanding role of genetic counseling in the context of
DTC genetic testing and the broad range of skills and
knowledge domains necessary to assist consumers with
their engagement with genotyping results [22]. Focusing
solely on providing traditional genetic counseling fails to
consider the spectrum of issues that may provoke ques-
tions by student participants.
Our study results reveal that student had a limited
recollection and understanding of the consent and bio-
banking agreements, pointing to the benefits of legal
and ethical consultants who can act as resources to
students unfamiliar with reviewing these documents.
Although the informed consent processes in the perso-
nal genome-testing industry are shifting [29], clear iden-
tification of when customers are merely consumers and
when they become research participants remains murky.
It is imperative that institutions provide support to stu-
dents on how to interpret the conditions of their purchase
of personal genome-testing services and how to manage
the potential longer-term relationship they may have with
these companies even after they complete the course
and graduate from their programs. A multi-disciplinary
approach to consultation services should be sufficiently
flexible to address student needs as the landscape of ser-
vices and quality of information evolves.
Conclusion
As academic institutions partner with DTC personal
genotyping services to create new curricula, careful con-
sideration of student needs and of the support services
made available to them is crucial. The experiences and
perspectives of students who have been genotyped in
the classroom setting should guide educators as they
build models for incorporating personal genotyping into
medical and graduate curricula. Student perspectives
indicate a need for improvements to achieve a more
nuanced treatment of the pedagogical needs of the stu-
dent population in question. In planning a new curricu-
lum, a multi-disciplinary approach, as taken by Stanford
University’s task force, would help to anticipate the
range of topics, including technical, clinical, social and
ethical issues, incumbent in offering or encouraging
genotyping in a course context. Building on this model,
the inclusion of students and/or community members
who have experienced genotyping would provide added
perspectives in anticipating the emerging needs of stu-
dent populations. Ongoing, innovative multi-disciplinary
consultation support would allow students the opportu-
nity to take full advantage of the learning experience by
confirming appropriate use of the tools and receiving
individualized attention when confronted with the prac-
tical and analytical challenges of interpreting the human
genome. These lessons provide a framework for the
development of a model for when personal genetic test-
ing is introduced in the classroom while minimizing
associated risks to students and beginning the important
work of creating best practices. Further research into
the experiences of students who are offered genotyping
in diverse educational settings and levels is needed to
equip institutional policies.
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